Claritev Corporation (CTEV) is a publicly traded Healthcare sector company. As of October 11, 2026, CTEV trades at $24.71 with a market cap of $417.92M and a P/E ratio of -1.37. CTEV moved +1.36% today. Year to date, CTEV is -27.24%; over the trailing twelve months it is -57.72%. Its 52-week range spans $11.50 to $74.07. Analyst consensus is strong buy with an average price target of $45.83. Rallies surfaces CTEV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks CTEV insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $24.71 |
| Market Cap | $417.92M |
| P/E Ratio | -1.37 |
| EPS | $-17.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.07 |
| 52-Week Low | $11.50 |
| Volume | 109.28K |
| Avg Volume | 0 |
| Revenue (TTM) | $965.41M |
| Net Income | $-284.28M |
| Gross Margin | 0.00% |
6 analysts cover CTEV: 0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.83.